Login / Signup

COVID-19 in patients with paracoccidioidomycosis.

Priscila Marques de MacedoLorena Macedo Pestana BenkoEduardo Mastrangelo Marinho FalcãoJoshua D NosanchukRodrigo Almeida-PaesAntonio Carlos Francesconi do Valle
Published in: PLoS neglected tropical diseases (2023)
There is a range of disease severity in COVID-19 and PCM co-infection and concomitant disease may represent a severe association, especially in the chronic type of the mycosis with pulmonary involvement. As COVID-19 and chronic PCM share similar clinical aspects and PCM is neglected, it is probable that COVID-19 has been hampering simultaneous PCM diagnosis, which can explain the absence of new co-infection reports. With the continued persistence of COVID-19 globally, these findings further suggest that more attention by providers is necessary to identify co-infections with Paracoccidioides.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • working memory
  • adverse drug
  • pulmonary hypertension